The impact of anti-TNF treatment on Wnt signaling, noggin, and cytokine levels in axial spondyloarthritis-Reference-Cited by-同舟云学术

The impact of anti-TNF treatment on Wnt signaling, noggin, and cytokine levels in axial spondyloarthritis

Published:2022-01-20 Issue:5 Volume:41 Page:1381-1389
ISSN:0770-3198
Container-title:Clinical Rheumatology
language:en
Short-container-title:Clin Rheumatol

Author:

Atas Nuh^ORCID,Çakır Bağdagül,Bakır Fatih,Uçar Murat,Satış Hasan,Güz Gizem Tuğçe,Demirel Kübra Durmuş,Babaoğlu Hakan,Salman Reyhan Bilici,Güler Aslıhan Avanoğlu,Karadeniz Hazan,Haznedaroğlu Şeminur,Göker Berna,Öztürk Mehmet Akif,Tufan Abdurrahman

Funder

Gazi Üniversitesi

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Rheumatology

Link

https://link.springer.com/content/pdf/10.1007/s10067-022-06070-w.pdf

Reference68 articles.

1. Sieper J, Poddubnyy D (2017) Axial spondyloarthritis. Lancet 390(10089):73–84. https://doi.org/10.1016/S0140-6736(16)31591-4

2. Schett G, Rudwaleit M (2010) Can we stop progression of ankylosing spondylitis? Best Pract Res Clin Rheumatol 24(3):363–371. https://doi.org/10.1016/j.berh.2010.01.005

3. van der Heijde D, Ramiro S, Landewe R, Baraliakos X, Van den Bosch F, Sepriano A et al (2017) 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis. Ann Rheum Dis 76(6):978–991. https://doi.org/10.1136/annrheumdis-2016-210770